SCHEMBL1083085

SCHEMBL1083085

CCCc1cc(C(=O)NC(Cc2ccccc2)C(O)C(=O)O)nn1Cc1cnc(-c2ccccc2-c2nnn[nH]2)cn1

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PYGL P06737 1/20 0.33
MME P08473 6/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL653745 1.00 PYGL (0.33) PYGLMME
SCHEMBL661038 0.91 MME (0.35) PYGLMME
SCHEMBL659719 0.91 MME (0.35) PYGLMME
SCHEMBL659720 0.91 MME (0.35) PYGLMME
SCHEMBL994219 0.91 MME (0.35) PYGLMME
SCHEMBL653065 0.91 MME (0.35) PYGLMME
SCHEMBL655002 0.88 CTSA (0.38) MME
SCHEMBL655001 0.88 CTSA (0.38) MME
SCHEMBL650255 0.87 MME (0.40) PYGLMME
SCHEMBL653395 0.84 MME (0.40) PYGLMME

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2451782-A1 DUAL-ACTING PYRAZOLE ANTIHYPERTENSIVE AGENTS Theravance, Inc. (US) 2012-05-16 EP disclosed
WO-2011005674-A1 DUAL-ACTING PYRAZOLE ANTIHYPERTENSIVE AGENTS THERAVANCE, INC. (US) 2011-01-13 WO disclosed